| Dasatinib |
达沙替尼 |
302962-49-8 |
| 1H-Pyrrole-2,5-dione, 3-[8-(aMinoMethyl)-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl]-4-(1-Methyl-1H-indol-3-yl)-, Monohy |
BISINDOLYLMALEIMIDE X HYDROCHLORIDE (BIM-X HYDROCHLORIDE) |
145317-11-9 |
| Vps34-IN-1 |
VPS34-IN1 |
1383716-33-3 |
| (4-(3-Benzyloxyphenyl)-2-ethylsulfinyl-6-(trifluoroMethyl)pyriMidine |
BETP |
1371569-69-5 |
| AZD-1390 |
CS-2816 |
2089288-03-7 |
| Isoquinoline, 1,2-dihydro-1-(1H-indol-3-yl)-2-[(phenylmethyl)sulfonyl]- |
313526-24-8 |
313526-24-8 |
| [1,2,4]Triazolo[1,5-a]pyridin-7-ol |
7-羟基-[1,2,4]三唑并[1,5-A]吡啶 |
1033810-70-6 |
| methyl ((1S,2R,3S,4R)-2,3-dihydroxy-4-((2-(3-((trifluoromethyl)thio)phenyl)pyrazolo[1,5-a]pyrimidin-7-yl)amino)cyclopentyl)sulfamate |
TAK-243 |
1450833-55-2 |
| AD80 |
AD80 |
1384071-99-1 |
| VU 0365114 |
1208222-39-2 |
1208222-39-2 |
| Tak-715 |
N-(4-(2-乙基-4-(3-甲基苯基)噻唑-5-基)吡啶-2-基)苯甲酰胺 |
303162-79-0 |
| (S)-3-((S)-2-(2-(2-tert-butylphenylamino)-2-oxoacetamido)propanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid |
N-[2-(叔丁基)苯基]-2-氧代甘氨酰-N-[(1S)-1-(羧基甲基)-2-氧代-3-(2,3,5,6-四氟苯氧基)丙基]-L-丙氨酰胺 |
254750-02-2 |
| SR 57227 HYDROCHLORIDE |
SR57227盐酸盐 |
77145-61-0 |
| O-(2-tert-butoxyethyl)hydroxylaMine |
O-(2-叔丁氧基乙基)羟胺 |
1023742-13-3 |
| NVP-BSK805 |
NVP-BSK805 dihydrochloride |
1092499-93-8 |
| Dabigatran etexilate |
达比加群酯 |
211915-06-9 |
| Nafamostat mesylate |
甲磺酸萘莫司他 |
82956-11-4 |
| Tandutinib |
坦度替尼 |
387867-13-2 |
| 2-(1H-INDOL-4-YL)ACETIC ACID |
2-(1H-吲哚)-4-乙酸 |
16176-74-2 |
| Salirasib |
法尼基硫代水杨酸 |
162520-00-5 |
